Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.25.0.1
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net revenue $ 25,785 $ 22,680 $ 23,601
Cost of sales 12,114 11,278 11,550
Cost, Depreciation, Amortization and Depletion 946 942 1,448
Total cost of sales 13,060 12,220 12,998
Gross profit 12,725 10,460 10,603
Research and development 6,456 5,872 5,005
Marketing, general and administrative 2,783 2,352 2,336
Amortization of acquisition-related intangibles_Opex 1,448 1,869 2,100
Restructuring charges 186 0 0
Licensing gain (48) (34) (102)
Operating income 1,900 401 1,264
Interest expense (92) (106) (88)
Other income (expense), net 181 197 8
Income before income taxes and equity income 1,989 492 1,184
Income tax provision (benefit) 381 (346) (122)
Equity income in investee 33 16 14
Net income $ 1,641 $ 854 $ 1,320
Earnings per share      
Basic (in usd per share) $ 1.01 $ 0.53 $ 0.85
Diluted (in usd per share) $ 1.00 $ 0.53 $ 0.84
Shares used in per share calculation      
Basic (in shares) 1,620 1,614 1,561
Diluted (in shares) 1,637 1,625 1,571